We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+21.25%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$128M
AUM Growth
–
Cap. Flow
+$121M
Cap. Flow %
95.08%
Top 10 Hldgs %
56.2%
Holding
52
New
52
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$11.6M
2
CALX icon
Calix
CALX
+$10.1M
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$6.92M
4
LSAK icon
Lesaka Technologies
LSAK
+$6.86M
5
BEAT
BioTelemetry, Inc.
BEAT
+$6.55M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 45.91%
2 Technology 33.09%
3 Materials 4.86%
4 Miscellaneous 4.56%
5 Communication Services 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGRO icon
51
Adecoagro
AGRO
$1.54B
$89K 0.07%
+14,300
New +$105K
GLOG
52
DELISTED
GASLOG LTD
GLOG
$18K 0.01%
+1,400
New +$18K
1 2
3

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Sophrosyne Capital, which disclosed 52 positions worth $128M. Its ten largest holdings account for 56% of the portfolio.

Its largest position is Strategy Inc: 1,244,630 shares worth $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, followed by Technology and Materials.

  • Sophrosyne Capital's largest Q2 2013 buy was Strategy Inc: 1,244,630 shares worth $10.8M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $128M portfolio in Q2 2013.
  • Sophrosyne Capital disclosed 52 positions in Q2 2013, its first 13F filing on record.

Based on Sophrosyne Capital's 13F filing for Q2 2013, filed 14 Aug 2013.